SMAD3 and melanoma: TGF-β increased MMP2 much more than MMP1, which is consistent with a recent study showing that in mouse models of melanoma and lung cancer, TGF-β-induced Smad3 upregulation acted as a main source of transcriptional activator for MMP2.49